ArticleBreast cancer (Dove Medical Press)2026
Endocrine Therapy versus Chemotherapy After CDK4/6 Inhibitor Progression in HR+/HER2- Metastatic Breast Cancer: A Multicenter Real-World Study from Turkey.
Can Cangür et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.